|Articles|October 14, 2019
SEC-MALS Method for Characterizing mRNA Biophysical Attributes
Author(s)Wyatt
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
VectorY Doses First Patient in TDP-43–Targeting ALS Trial
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
Ivonescimab Breakthrough Designation Highlights Progress in BTC Treatment
4
Women in STEM: Building Sustainable Cost and Access Models for Advanced Therapies (Part 1)
5